Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-15 10:33 am Unchanged | 13D | DELCATH SYSTEMS INC. DCTH | Rosalind Advisors Inc. | 2,763,468 9.900% | 0 (Unchanged) | View |
| 2024-11-14 9:46 pm Unchanged | 13D | DELCATH SYSTEMS INC. DCTH | Rosalind Advisors Inc. | 2,763,468 9.900% | 0 (Unchanged) | View |
| 2024-11-06 10:48 am Sale | 13G | BIOFRONTERA INC BFRI | Rosalind Advisors Inc. | 7,196,776 6.900% | -675,713 (-8.58%) | View |
| 2024-10-28 4:02 pm Unchanged | 13G | INSPIREMD INC NSPR | Rosalind Advisors Inc. | 7,438,181 9.800% | 0 (Unchanged) | View |
| 2024-10-23 3:14 pm Unchanged | 13G | BIOFRONTERA INC BFRI | Rosalind Advisors Inc. | 7,872,489 8.900% | 0 (Unchanged) | View |
| 2024-10-23 3:05 pm Unchanged | 13G | PolyPid Ltd. PYPD | Rosalind Advisors Inc. | 686,172 9.900% | 0 (Unchanged) | View |
| 2024-10-23 2:57 pm Purchase | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 628,050 5.800% | 114,560 (+22.31%) | View |
| 2024-10-23 2:44 pm Sale | 13G | TREVI THERAPEUTICS INC TRVI | Rosalind Advisors Inc. | 750,000 1.030% | -641,577 (-46.10%) | View |
| 2024-10-23 2:26 pm Sale | 13G | SPRUCE BIOSCIENCES INC SPRB | Rosalind Advisors Inc. | 0 0.000% | -1,508,419 (Position Closed) | View |
| 2024-10-18 2:52 pm Purchase | 13G | OPTINOSE INC OPTN | Rosalind Advisors Inc. | 8,287,503 5.500% | 740,355 (+9.81%) | View |
| 2024-10-18 2:21 pm Unchanged | 13G | MYOMO INC. MYO | Rosalind Advisors Inc. | 4,575,385 9.900% | 0 (Unchanged) | View |
| 2024-08-14 7:20 pm Purchase | 13G | PolyPid Ltd. PYPD | Rosalind Advisors Inc. | 686,172 9.900% | 686,172 (New Position) | View |
| 2024-08-14 7:15 pm Purchase | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors Inc. | 6,970,425 9.900% | 2,977,839 (+74.58%) | View |
| 2024-07-12 10:35 am Unchanged | 13G | MYOMO INC. MYO | Rosalind Advisors Inc. | 4,575,385 9.900% | 0 (Unchanged) | View |
| 2024-07-11 6:02 pm Unchanged | 13G | MYOMO INC. MYO | Rosalind Advisors Inc. | 4,575,385 9.900% | 0 (Unchanged) | View |
| 2024-07-11 5:52 pm Purchase | 13G | TREVI THERAPEUTICS INC TRVI | Rosalind Advisors Inc. | 1,391,577 1.980% | 465,561 (+50.28%) | View |
| 2024-07-11 5:48 pm Sale | 13G | INSPIREMD INC NSPR | Rosalind Advisors Inc. | 7,438,181 9.900% | -21,747 (-0.29%) | View |
| 2024-07-11 5:43 pm Purchase | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 513,490 7.160% | 27,500 (+5.66%) | View |
| 2024-07-11 5:37 pm Unchanged | 13G | CELLECTAR BIOSCIENCES INC CLRB | Rosalind Advisors Inc. | 3,992,586 9.900% | 0 (Unchanged) | View |
| 2024-05-29 3:47 pm Unchanged | 13G | KIORA PHARMACEUTICALS INC KPRX | Rosalind Advisors Inc. | 4,182,094 9.900% | 0 (Unchanged) | View |